These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27390721)

  • 21. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue.
    Hüppi PS; Fusch C; Boesch C; Burri R; Bossi E; Amato M; Herschkowitz N
    Pediatr Res; 1995 Feb; 37(2):145-50. PubMed ID: 7731750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of posterior temporal-parietal hematoma on orbital frontal chemistry in relation to a cognitive and anxiety state: a combined 1H-MRS and neuropsychological study of an unusual case as compared with 16 healthy subjects.
    Grachev ID; Kumar R; Swarnkar A; Chang JK; Ramachandran TS
    J Chem Neuroanat; 2002 Mar; 23(3):223-30. PubMed ID: 11861128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
    Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontal and thalamic changes of GABA concentration indicate dysfunction of thalamofrontal networks in juvenile myoclonic epilepsy.
    Hattingen E; Lückerath C; Pellikan S; Vronski D; Roth C; Knake S; Kieslich M; Pilatus U
    Epilepsia; 2014 Jul; 55(7):1030-7. PubMed ID: 24902613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy--a proton-MRS study at 3 Tesla.
    Riederer F; Bittsanský M; Lehner-Baumgartner E; Baumgartner C; Mlynárik V; Gruber S; Moser E; Kaya M; Serles W
    Brain Res; 2007 Nov; 1179():131-9. PubMed ID: 17936253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings.
    Courvoisie H; Hooper SR; Fine C; Kwock L; Castillo M
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):63-9. PubMed ID: 14990761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
    Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
    Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.
    Frey R; Metzler D; Fischer P; Heiden A; Scharfetter J; Moser E; Kasper S
    J Psychiatr Res; 1998; 32(6):411-20. PubMed ID: 9844958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS; Ivanovski B; Wen W; Lagopoulos J; Moss K; Sachdev P
    Acta Psychiatr Scand Suppl; 2007; (434):57-66. PubMed ID: 17688464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder.
    Hamakawa H; Kato T; Shioiri T; Inubushi T; Kato N
    Psychol Med; 1999 May; 29(3):639-44. PubMed ID: 10405085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy.
    Tong J; Geng H; Zhang Z; Zhu X; Meng Q; Sun X; Zhang M; Qian R; Sun L; Liang Q
    Magn Reson Imaging; 2014 Oct; 32(8):1037-42. PubMed ID: 24985566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline of frontal lobe functions in subjects with age-associated memory impairment.
    Hänninen T; Hallikainen M; Koivisto K; Partanen K; Laakso MP; Riekkinen PJ; Soininen H
    Neurology; 1997 Jan; 48(1):148-53. PubMed ID: 9008510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Watanabe T; Shiino A; Akiguchi I
    Neurobiol Learn Mem; 2012 Mar; 97(3):289-93. PubMed ID: 22390859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
    Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
    J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
    Voevodskaya O; Poulakis K; Sundgren P; van Westen D; Palmqvist S; Wahlund LO; Stomrud E; Hansson O; Westman E;
    Neurology; 2019 Jan; 92(5):e395-e405. PubMed ID: 30610093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in cerebral metabolites in type 2 diabetes mellitus: A meta-analysis of proton magnetic resonance spectroscopy.
    Wu GY; Zhang Q; Wu JL; Jing L; Tan Y; Qiu TC; Zhao J
    J Clin Neurosci; 2017 Nov; 45():9-13. PubMed ID: 28765058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.